We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 29 results
  1. Estimands in epigenome-wide association studies

    Background

    In DNA methylation analyses like epigenome-wide association studies, effects in differentially methylated CpG sites are assessed. Two kinds...

    Jochen Kruppa, Miriam Sieg, ... Anne Pohrt in Clinical Epigenetics
    Article Open access 29 April 2021
  2. Confirmatory prediction-driven RCTs in comparative effectiveness settings for cancer treatment

    Background

    Medical advances in the treatment of cancer have allowed the development of multiple approved treatments and prognostic and predictive...

    Adam Brand, Michael C. Sachs, ... Erin E. Gabriel in British Journal of Cancer
    Article Open access 23 January 2023
  3. Strategies to manage auxiliary pain medications in chronic pain trials: a topical review

    Chronic pain trials commonly allow auxiliary pain medications such as rescue and concomitant analgesics in addition to the randomized treatment....

    Eivind Hasvik, Jon Michael Gran, ... Lars Grøvle in European Journal of Clinical Pharmacology
    Article Open access 16 July 2022
  4. The UK BiLEVE and Mendelian randomisation: using multivariable instrumental variables to address “damned if you, damned if you don’t” adjustment problems

    Objective

    To explore the use of multivariable instrumental variables to resolve the “damned if you do, damned if you don’t” adjustment problem created...

    Benjamin Woolf, Dipender Gill, ... Marcus R. Munafò in BMC Research Notes
    Article Open access 25 July 2023
  5. General Overview of the Statistical Issues in Clinical Study Designs

    This chapter introduces statistical issues often encountered in confirmatory clinical studies in a typical setting - randomized trials with parallel...
    Chapter 2023
  6. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

    The STEP 5 trial assessed the efficacy and safety of once-weekly subcutaneous semaglutide 2.4 mg versus placebo (both plus behavioral intervention)...

    W. Timothy Garvey, Rachel L. Batterham, ... Sean Wharton in Nature Medicine
    Article Open access 10 October 2022
  7. Common Clinical Trial Designs

    Clinical Trials are studies conducted for the purpose of assessing the effect of an intervention in a defined population, or to evaluate one or more...
    Chapter 2023
  8. Do beta-blockers reduce negative intrusive thoughts and anxiety in cancer survivors? – An emulated trial

    Background

    High rates of negative intrusive thoughts have been reported among cancer patients. Prevalent users of beta-blocker therapy have reported...

    Carolina Ehrencrona, Ying Li, ... David Bock in BMC Cancer
    Article Open access 11 April 2024
  9. Deriving GWAS summary estimates for paternal smoking in UK biobank: a GWAS by subtraction

    Objective

    To use genome-wide association study (GWAS) by subtraction, a method for deriving novel GWASs from existing summary statistics, to derive...

    Benjamin Woolf, Hannah M. Sallis, ... Dipender Gill in BMC Research Notes
    Article Open access 30 July 2023
  10. The Importance of Assessing Drug Exposure and Medication Adherence in Evaluating Investigational Medications: Ensuring Validity and Reliability of Clinical Trial Results

    The objective of this current opinion paper is to draw global attention to medication adherence, emphasizing its crucial role in drug trials....

    Bernard Vrijens, Antoine Pironet, Eric Tousset in Pharmaceutical Medicine
    Article Open access 22 December 2023
  11. Variability and uncertainty: interpretation and usage of pharmacometric simulations and intervals

    Variability and estimation uncertainty are important sources of variation in pharmacometric simulations. Different combinations of uncertainty and...

    Article 04 August 2022
  12. Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial

    Background

    Older primary central nervous system lymphoma (PCNSL) patients have an inferior prognosis compared to younger patients because available...

    Lisa K Isbell, Roswitha Uibeleisen, ... Elisabeth Schorb in BMC Cancer
    Article Open access 18 August 2023
  13. Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial

    In the STEP-HFpEF trial, semaglutide improved symptoms, physical limitations and exercise function and reduced body weight in patients with obesity...

    Barry A. Borlaug, Dalane W. Kitzman, ... Mikhail N. Kosiborod in Nature Medicine
    Article Open access 27 August 2023
  14. The Randomised Controlled Trial at the Intersection of Research Ethics and Innovation

    The randomised controlled trial (RCT) has been considered for a long time as the gold standard for evidence generation to support regulatory decision...

    Torbjörn Callréus in Pharmaceutical Medicine
    Article 25 July 2022
  15. Confidence bands in survival analysis

    Background

    Providing estimates of uncertainty for statistical quantities is important for statistical inference. When the statistical quantity of...

    Michael C. Sachs, Adam Brand, Erin E. Gabriel in British Journal of Cancer
    Article Open access 19 August 2022
  16. Can incorporating genoty** data into efficacy estimators improve efficiency of early phase malaria vaccine trials?

    Background

    Early phase malaria vaccine field trials typically measure malaria infection by PCR or thick blood smear microscopy performed on serially...

    Gail E. Potter, Viviane Callier, ... Gregory A. Deye in Malaria Journal
    Article Open access 19 December 2023
  17. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial

    The effects of tirzepatide, a glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, on weight reduction after...

    Thomas A. Wadden, Ariana M. Chao, ... Tammy Forrester in Nature Medicine
    Article Open access 15 October 2023
  18. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study

    Post-traumatic stress disorder (PTSD) presents a major public health problem for which currently available treatments are modestly effective. We...

    Jennifer M. Mitchell, Michael Bogenschutz, ... Rick Doblin in Nature Medicine
    Article Open access 10 May 2021
  19. Accurate estimation of SNP-heritability from biobank-scale data irrespective of genetic architecture

    SNP-heritability is a fundamental quantity in the study of complex traits. Recent studies have shown that existing methods to estimate genome-wide...

    Kangcheng Hou, Kathryn S. Burch, ... Bogdan Pasaniuc in Nature Genetics
    Article 29 July 2019
Did you find what you were looking for? Share feedback.